We are live on ! Find out more
IBER.U

Ibere Pharmaceuticals Units

Delisted

IBER.U was delisted on the 1st of March, 2023.

34 hedge funds and large institutions have $61.7M invested in Ibere Pharmaceuticals Units in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

43% less funds holding

Funds holding: 60 → 34 (-26)

93% less capital inflows, than outflows

Capital inflows: $4.41M | Capital outflows: $61.3M

96% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 26

Holders
34
Holders Change
-26
Holders Change %
-43.33%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
6
Reduced
8
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IBER.U Hedge Fund Activity: Q2 2021 in Review

34 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units (IBER.U) for Q2 2021, worth a combined $61.7M — down 49% from $121M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of IBER.U and 1 opened new positions — a net loss of 25 holders — while 8 trimmed existing stakes and 6 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $306K. The largest seller was Citadel Advisors, cutting an estimated $5.47M.

  • 34 institutional investors held Ibere Pharmaceuticals Units (IBER.U) as of Q2 2021, down from 60 in Q1 2021.
  • Funds reported $61.7M of Ibere Pharmaceuticals Units stock for Q2 2021, down 49% quarter-over-quarter.
  • 1 fund opened new Ibere Pharmaceuticals Units positions in Q2 2021 and 26 closed out, a net change of -25 holders.
  • The largest Ibere Pharmaceuticals Units buyer in Q2 2021 was D.E. Shaw & Co, an estimated $306K added.
  • The largest Ibere Pharmaceuticals Units seller in Q2 2021 was Citadel Advisors, an estimated $5.47M sold.

Based on aggregated 13F filings for Q2 2021.